Titre : MAVIRET (Glecaprevir/pibrentasvir) treats hepatitis C in HIV-coinfected individuals
link : MAVIRET (Glecaprevir/pibrentasvir) treats hepatitis C in HIV-coinfected individuals
MAVIRET (Glecaprevir/pibrentasvir) treats hepatitis C in HIV-coinfected individuals
Glecaprevir/pibrentasvir treats hepatitis C in HIV-coinfected individuals
Last Updated: 2018-04-02
By Reuters Staff
NEW YORK (Reuters Health) - The direct-acting antiviral (DAA) combination glecaprevir/pibrentasvir is effective for treating hepatitis C virus (HCV) infection in individuals coinfected with HIV-1, according to results from the non-randomized, open-label phase 3 EXPEDITION-2 trial. As many as 3 million of the 80 million individuals infected with HCV worldwide are coinfected with HIV-1. Most guidelines recommend these patients be treated like those with HCV monoinfection, with careful monitoring for drug-drug interactions with antiretroviral therapy (ART)....
Last Updated: 2018-04-02
By Reuters Staff
NEW YORK (Reuters Health) - The direct-acting antiviral (DAA) combination glecaprevir/pibrentasvir is effective for treating hepatitis C virus (HCV) infection in individuals coinfected with HIV-1, according to results from the non-randomized, open-label phase 3 EXPEDITION-2 trial. As many as 3 million of the 80 million individuals infected with HCV worldwide are coinfected with HIV-1. Most guidelines recommend these patients be treated like those with HCV monoinfection, with careful monitoring for drug-drug interactions with antiretroviral therapy (ART)....
http://www.chronicliverdisease.org/reuters/article.cfm?article=20180402Other1554755267
Study: Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study
Study: Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study
Thus articles MAVIRET (Glecaprevir/pibrentasvir) treats hepatitis C in HIV-coinfected individuals
that is all articles MAVIRET (Glecaprevir/pibrentasvir) treats hepatitis C in HIV-coinfected individuals This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article MAVIRET (Glecaprevir/pibrentasvir) treats hepatitis C in HIV-coinfected individuals the link address https://newsaninpiration.blogspot.com/2018/04/maviret-glecaprevirpibrentasvir-treats.html
0 Response to "MAVIRET (Glecaprevir/pibrentasvir) treats hepatitis C in HIV-coinfected individuals"
Post a Comment